In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Qiagen NV

Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio

Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.

M & A Deals

Coronavirus Antigen Testing Gets Green Light In Germany

Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.

Diagnostics Germany

Qiagen Ready To Rival Abbott With Rapid, Portable Antigen COVID-19 Test

The diagnostics company said the test is scheduled for US launch in Q4 2020.

Coronavirus COVID-19 In Vitro Diagnostics

Deal Watch: RedHill Finds New Partner For Movantik

Having licensed rights to Movantik from AstraZeneca in February, RedHill has now offloaded EU rights to Cosmo. Calliditas to obtain PBC candidate in bid to acquire Genkyotex.

Deals Business Strategies
See All

Company Information

  • Industry
  • Services
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • Other Names / Subsidiaries
    • Amnisure International LLC
    • Biobase, Biotage
    • Corbett Life Science Pty. Ltd.
    • Digene Corporation
    • DxS
    • eGene, Inc.
    • ESE GmbH
    • Exiqon
    • Ingenuity Systems Inc
    • Genaco Biomedical Products, Inc.
    • MAQGEN
    • MO BIO Laboratories
    • NeuMoDx Molecular, Inc.
    • OmicSoft Corporation
    • SABiosciences Corporation
    • Ipsogen S.A.
    • Qiagen Manchester Limited
    • Qiagen N.V.
    • Xeragon Inc.
UsernamePublicRestriction

Register